Update on management and progress of novel therapeutics for R/R AML: an Iberian expert panel consensus (vol 47, pg 568, 2020)

Por: Montesinos, P, Bergua, J, Infante, J, Esteve, J, Guimaraes, JE, Sierra, J, Sanz, MA

---

Publicada: 1 mar 2020 Ahead of Print: 1 ene 2020

---

---

Filiaciones:
Montesinos, P:
 Hosp Univ & Politecn La Fe, Dept Hematol, Ave Fernando Abril Martorell 106, Valencia 46026, Spain

 CIBERONC Inst Salud Carlos III, Madrid, Spain

Bergua, J:
 Hosp San Pedro Alcantara, Div Hematol Oncol, Caceres, Spain

Infante, J:
 Hosp SantaMaria, Serv Hematol & Transplantacao Medula Ossea, Ctr Hosp Lisboa Norte, Lisbon, Portugal

Esteve, J:
 IDIBAPS Hosp Clin, Dept Hematol, Barcelona, Spain

Guimaraes, JE:
 Ctr Hosp Univ Sao Joao, Serv Hematol Clin, Porto, Portugal

Sierra, J:
 Autonomous Univ Barcelona, Dept Hematol, Hosp Santa Creu & St Pau, IIB St Pau Inst, Barcelona, Spain

 Autonomous Univ Barcelona, Dept Hematol, Hosp Santa Creu & St Pau, Jose Carreras Leukemia Res Inst, Barcelona, Spain

Sanz, MA:
 Hosp Univ & Politecn La Fe, Dept Hematol, Ave Fernando Abril Martorell 106, Valencia 46026, Spain